Health and Medicine
-
October 11, 2013
New target for stopping inflammation
Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases. -
October 10, 2013
Student’s neurosurgical fellowship spurs research
Travis Ladner, a third-year student at the Vanderbilt University School of Medicine, has been selected for a 2013 Congress of Neurological Surgeons (CNS) student fellowship award. The award is presented to a medical student every year from a national pool of applicants. -
October 10, 2013
Grant bolsters study of nursing workforce’s future
Vanderbilt University’s Center for Interdisciplinary Health Workforce Studies has been awarded $2.2 million from the Gordon and Betty Moore Foundation to address nursing workforce issues that may impede future health care. -
October 10, 2013
Probing mutant EGF receptor regulation
Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. -
October 7, 2013
New faculty: Jay Wellons brings national research network to Children’s Hospital
When physician Jay Wellons was explaining to his son why the family was moving to Nashville, he put it in terms to which the 7-year-old could relate. “Daddy has a chance to join the Avengers,” he said. -
October 3, 2013
Study finds cognitive deficits common after critical illness
Patients treated in intensive care units across the globe enter their medical care with no evidence of cognitive impairment but often leave with deficits similar to those seen in patients with traumatic brain injury (TBI) or mild Alzheimer’s disease (AD) that persist for at least a year, according to a Vanderbilt University Medical Center study published today in the New England Journal of Medicine. -
October 3, 2013
Framingham Heart Study’s landmark impact examined
While the Framingham Heart Study is often referenced throughout the halls of academia, few know its origin or can fully appreciate the contribution it has made to the understanding and prevention of cardiovascular disease.